These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16612309)

  • 1. Nafamostat attenuated the impairment of fibrinolysis in animal sepsis model by suppressing the increase of plasminogen activator inhibitor type 1.
    Hryszko T; Inaba K; Ihara H; Suzuki Y; Mogami H; Urano T
    J Trauma; 2006 Apr; 60(4):859-64. PubMed ID: 16612309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats.
    Muto Y; Suzuki K; Iida H; Sakakibara S; Kato E; Itoh F; Kakui N; Ishii H
    Crit Care Med; 2009 May; 37(5):1744-9. PubMed ID: 19325462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection.
    Shimada M; Matsumata T; Shirabe K; Kamakura T; Taketomi A; Sugimachi K
    J Am Coll Surg; 1994 May; 178(5):498-502. PubMed ID: 8167888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
    Am J Respir Crit Care Med; 1997 Feb; 155(2):711-8. PubMed ID: 9032217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
    Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
    Thromb Res; 2009 May; 124(1):110-5. PubMed ID: 19195683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of activated protein C on coagulation and fibrinolysis in rabbits with endotoxin induced acute lung injury.
    He HY; Wang C; Pang BS
    Chin Med J (Engl); 2008 Dec; 121(24):2561-5. PubMed ID: 19187596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
    Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
    Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
    Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
    Hagiwara S; Iwasaka H; Noguchi T
    J Anesth; 2007; 21(2):164-70. PubMed ID: 17458645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway.
    Kwak SH; Wang XQ; He Q; Fang WF; Mitra S; Bdeir K; Ploplis VA; Xu Z; Idell S; Cines D; Abraham E
    Thromb Haemost; 2006 May; 95(5):829-35. PubMed ID: 16676075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of nafamostat mesilate in early wound healing.
    Tsutamoto Y; Tani T; Eguchi Y; Araki H; Kodama M
    J Am Coll Surg; 1997 Jun; 184(6):637-44. PubMed ID: 9179121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
    Jesmin S; Gando S; Zaedi S; Sakuraya F
    Thromb Haemost; 2006 Dec; 96(6):830-8. PubMed ID: 17139380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Xuebijing injection on protein C and tumor necrosis factor-alpha mRNA in rats with sepsis].
    Li YP; Qiao YJ; Wu ZX; Qian FF; Yao YM; Yu Y; Wu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Aug; 19(8):488-91. PubMed ID: 17708848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.